The impact of gender and NASH on chronic kidney disease before and after liver transplantation

Liver International

Volumn 34, Issue 8, 2014, Pages 1259-1266

  Fussner, Lynn A ^a   Charlton, Michael R ^a   Heimbach, Julie K ^a   Fan, Chun ^a   Dierkhising, Ross ^a   Coss, Elizabeth ^a   Watt, Kymberly D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Chronic kidney disease; Diabetes; Female; Non alcoholic steatohepatitis; Renal failure

Indexed keywords

IOTALAMIC ACID;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; KIDNEY FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; RISK FACTOR; SEX DIFFERENCE; ADVERSE EFFECTS; COMPLICATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; RISK;

ADULT; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IOTHALAMIC ACID; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEX FACTORS;

EID: 84905752000     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12381     Document Type: Article

References (26)

1. de Boccardo G, Kim JY, Schiano TD, et al. The burden of chronic kidney disease in long-term liver transplant recipients. Transpl Proc 2008; 40: 1498-503.
2. Simo KA, Sereika S, Bitner N, Newton KN, Gerber DA. Medical epidemiology of patients surviving ten years after liver transplantation. Clin Transplant 2011; 25: 360-7.
3. Watt K, Pedersen R, Kremers W, Heimbach J, Charlton M. Evolution of Causes and risk factors for mortality post liver transplant: results of the NIDDK long term follow-up study. Am J Transplant 2010; 10: 1-8.
4. Ramachandran J, Juneja R, John L, et al. Chronic kidney disease following liver transplantation: a South Australian experience. Transpl Proc 2010; 42: 3644-6.
5. Srinivas TR, Stephany BR, Budev M, et al. An emerging population: kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation. Clin J Am Soc Nephrol 2010; 5: 1881-6.
6. Asrani SK, Leise MD, West CP, et al. Use of sirolimus in liver transplant recipients with renal insufficiency: a systematic review and meta-analysis. Hepatology 2010; 52: 1360-70.
7. Herlenius G, Felldin M, Norden G, et al. Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: results of a prospective randomized trial. Transpl Proc 2010; 42: 4441-8.
8. Kim JY, Akalin E, Dikman S, et al. The variable pathology of kidney disease after liver transplantation. Transplantation 2010; 89: 215-21.
9. Laryea M, Watt KD, Molinari M, et al. Metabolic Syndrome in liver transplant recipients: prevalence and association with cardiovascular events. Liver Transpl 2007; 13: 1109-14.
10. Leithead JA, Ferguson JW, Hayes PC. Modifiable patient factors are associated with the late decline in renal function following liver transplantation. Clin Transplant 2012; 26: E316-23.
11. Burra P, Senzolo M, Masier A, et al. Factors influencing renal function after liver transplantation. results from the MOST, an international observational study. Dig Liver Dis 2009; 41: 350-6.
12. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-40.
13. Levey AS, Coresh J, Greene T, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53: 766-72.
14. Carrero JJ. Gender differences in chronic kidney disease: underpinnings and therapeutic implications. Kidney Blood Press Res 2010; 33: 383-92.
15. Coggins CH, Breyer Lewis J, Caggiula AW, et al. Differences between women and men with chronic renal disease. Nephrol Dial Transplant 1998; 13: 1430-7.
16. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 2000; 11: 319-29.
17. Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med 2008; 5 Suppl A: S3-10.
18. Guitard J, Ribes D, Kamar N, et al. Predictive factors for chronic renal failure one year after orthotopic liver transplantation. Ren Fail 2006; 28: 419-25.
19. Aller R, de Luis DA, Moreira V, et al. The effect of liver transplantation on circulating levels of estradiol and progesterone in male patients: parallelism with hepatopulmonary syndrome and systemic hyperdynamic circulation improvement. J Endocrinol Invest 2001; 24: 503-9.
20. Madersbacher S, Ludvik G, Stulnig T, Grunberger T, Maier U. The impact of liver transplantation on endocrine status in men. Clin Endocrinol (Oxf) 1996; 44: 461-6.
21. Cundy TF, Butler J, Pope RM, et al. Amenorrhoea in women with non-alcoholic chronic liver disease. Gut 1991; 32: 202-6.
22. Cholongitas E, Marelli L, Kerry A, et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores-a systematic bias. Am J Transplant 2007; 7: 685-92.
23. Finkenstedt A, Dorn L, Edlinger M, et al. Cystatin C is a strong predictor of survival in patients with cirrhosis: is a cystatin C-based MELD better? Liver Int 2012; 32: 1211-6.
24. Houlihan DD, Armstrong MJ, Davidov Y, et al. Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens? Liver Transpl 2011; 17: 1292-8.
25. Machado MV, Goncalves S, Carepa F, et al. Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease. Liver Int 2012; 32: 241-8.
26. Targher G, Bertolini L, Rodella S, et al. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol 2010; 5: 2166-71.